Processa Pharmaceuticals Inc.

09/10/2025 | Press release | Distributed by Public on 09/10/2025 08:42

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders

On September 2, 2025 Processa Pharmaceuticals, Inc. convened its Special Shareholder Meeting at 1:00 PM ET in Pasadena, CA.

The meeting, which was adjourned until September 12, 2025, at 5:00 PM in Vero Beach, FL will now be reconvened on September 11, 2025 at 10:30 AM ET at the corporate office in Vero Beach, FL.

The Company will not change the record date of the Annual Meeting. Accordingly, only stockholders of record at the close of business on August 7, 2025, will be entitled to vote at the reconvened Annual Meeting.

Stockholders who have previously submitted their proxy or otherwise voted and who do not wish to change their vote do not need to take any action. The proposals for the meeting remain unchanged, and the proxy statement and other SEC filings are available on the SEC's website at www.sec.gov.

Processa Pharmaceuticals Inc. published this content on September 10, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 10, 2025 at 14:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]